
Strykr Analysis
BullishStrykr Pulse 68/100. Rotation into defensives is gaining traction as tech stalls. Threat Level 2/5. Macro risks remain, but risk/reward is attractive for healthcare.
If you’re looking for a market that’s quietly plotting its comeback while everyone else is busy arguing about Nvidia’s quarterly results, look no further than healthcare. While tech’s AI narrative is starting to look a little tired, Ed Yardeni is calling the software rally “overdone,” and even Jim Cramer is telling viewers not to read too much into today’s price action, there’s a stealth rotation brewing under the surface. The healthcare sector, long the wallflower at the bull market party, is suddenly getting a second look from traders who are tired of chasing overbought tech and want something with a little more substance.
The evidence is piling up. Seeking Alpha’s latest sector rotation note calls out healthcare (XLV) as the next stop for capital fleeing tech’s gravity well. The logic is simple: with the Magnificent Seven’s concentration at historic highs and upside catalysts running dry, the case for defensives is getting stronger by the day. XLP’s run has left it overbought, and healthcare is next in line. You can practically hear the portfolio managers dusting off their Pfizer and UnitedHealth models.
Let’s talk facts. The last 24 hours have seen a flurry of commentary about the state of the bull market. Nvidia’s earnings were strong, but the market yawned. The S&P 500 is stalling, and even the Nasdaq can’t muster a breakout. Ed Yardeni is warning that AI’s impact on software stocks is “overdone,” while Nuveen’s Saira Malik is bracing for volatility ahead. Meanwhile, Seeking Alpha is highlighting healthcare as the sector to watch. The rotation is subtle, but it’s there: money is moving out of tech and into defensives, with healthcare leading the charge.
This isn’t just a tactical trade. The macro backdrop is shifting. Inflation is proving sticky, with January’s PPI coming in at 0.3% month-over-month, according to Barron’s. The Fed’s balance sheet is still a wild card, and Kevin Warsh’s WSJ op-ed reminds us that shrinking it won’t be as easy as expanding it. The result is a market that’s losing faith in the easy-money, growth-at-any-price playbook. Defensive sectors like healthcare are suddenly looking attractive, not just as a hedge, but as a source of real, sustainable returns.
Historically, sector rotations like this don’t announce themselves with fireworks. They creep up on you, as capital quietly shifts from the winners to the laggards. In 2021, healthcare lagged tech by nearly 20 percentage points. By 2023, the gap had narrowed as defensives outperformed during bouts of macro uncertainty. The current setup is even more compelling: tech is overbought, sentiment is turning cautious, and healthcare valuations are still reasonable by historical standards.
The technicals back this up. XLV, the healthcare ETF, is showing signs of accumulation. Relative strength is improving, and the sector is starting to outperform the broader market on a rolling 3-month basis. The rotation out of tech and into healthcare isn’t a stampede yet, but it’s gathering steam. For traders who are tired of chasing the AI hype, this is the playbook: buy the laggards before everyone else catches on.
Strykr Watch
Healthcare is sitting at a technical inflection point. XLV is consolidating just below its 200-day moving average, with support at $130 and resistance at $135. Momentum is building, with RSI ticking up towards 60. The sector is still underowned relative to history, which means there’s plenty of room for catch-up. If XLV can clear $135 on volume, the path to $140 opens up quickly. On the downside, a break below $130 would invalidate the rotation thesis and put defensives back in the penalty box.
The rotation is also showing up in cross-asset flows. Defensive sectors are attracting inflows, while tech is seeing outflows for the first time in months. The market is starting to price in a more cautious macro regime, with volatility picking up and risk appetite fading. For traders, the message is clear: don’t sleep on healthcare. The rotation is real, and the risk/reward is compelling.
Strykr Take
Healthcare is quietly setting up as the next big rotation trade. With tech running on fumes and defensives back in vogue, the sector offers a rare combination of value, momentum, and macro tailwinds. The technicals are lining up, and the flows are confirming the shift. For traders who want to get ahead of the crowd, this is the moment to act. Don’t wait for the headlines, by the time everyone’s talking about healthcare, the easy money will be gone.
Date published: 2026-02-27 01:16 UTC
Sources (5)
Don't take today a referendum on anything, says Jim Cramer
'Mad Money' host Jim Cramer is making sense of Nvidia's quarterly results and the stock action.
AI's impact on software stock prices is overdone, says Yardeni Research's Ed Yardeni
Ed Yardeni, Yardeni Research president, joins 'Closing Bell' to discuss his thoughts on the tech trade, the market's standings and much more.
Markets are 'in for some volatility' this year, says Nuveen's Saira Malik
Saira Malik, Nuveen Chief Investment Officer, joins 'Closing Bell Overtime' to talk what to expect from markets in the year to come.
Sector Rotation: Healthcare XLV Should Be The Next Stop
The healthcare sector is poised to benefit next from the ongoing market rotation to value and defensives. XLP's rapid ascent has led to overbought tec
This Bull Market And Nvidia Have Run Out Of Steam; Bear Market Ahead?
The stock market is at a critical juncture, with major indexes stalled and upside catalysts lacking. Strong earnings, including Nvidia's, failed to ig
